Literature DB >> 16189322

Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum.

T Kobayashi1, H Watanabe, T Yanagawa, S Tsutsumi, M Kayakabe, T Shinozaki, H Higuchi, K Takagishi.   

Abstract

Human bone-marrow mesenchymal stem cells have an important role in the repair of musculoskeletal tissues by migrating from the bone marrow into the injured site and undergoing differentiation. We investigated the use of autologous human serum as a substitute for fetal bovine serum in the ex vivo expansion medium to avoid the transmission of dangerous transfectants during clinical reconstruction procedures. Autologous human serum was as effective in stimulating growth of bone-marrow stem cells as fetal bovine serum. Furthermore, medium supplemented with autologous human serum was more effective in promoting motility than medium with fetal bovine serum in all cases. Addition of B-fibroblast growth factor to medium with human serum stimulated growth, but not motility. Our results suggest that autologous human serum may provide sufficient ex vivo expansion of human bone-marrow mesenchymal stem cells possessing multidifferentiation potential and may be better than fetal bovine serum in preserving high motility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189322     DOI: 10.1302/0301-620X.87B10.16160

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  18 in total

1.  Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

Authors:  Osamu Honmou; Kiyohiro Houkin; Takuya Matsunaga; Yoshiro Niitsu; Sumio Ishiai; Rie Onodera; Stephen G Waxman; Jeffery D Kocsis
Journal:  Brain       Date:  2011-04-14       Impact factor: 13.501

Review 2.  Current status of cell therapies in stroke.

Authors:  Oh Young Bang
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

3.  Clinical grade adult stem cell banking.

Authors:  Sreedhar Thirumala; W Scott Goebel; Erik J Woods
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

Review 4.  Use of platelet lysate for bone regeneration - are we ready for clinical translation?

Authors:  Ala Altaie; Heather Owston; Elena Jones
Journal:  World J Stem Cells       Date:  2016-02-26       Impact factor: 5.326

5.  "Humanized" stem cell culture techniques: the animal serum controversy.

Authors:  Chandana Tekkatte; Gency Ponrose Gunasingh; K M Cherian; Kavitha Sankaranarayanan
Journal:  Stem Cells Int       Date:  2011-04-03       Impact factor: 5.443

Review 6.  Serum-Free Cultures: Could They Be a Future Direction to Improve Neuronal Differentiation of Mesenchymal Stromal Cells?

Authors:  Giovanni Schepici; Agnese Gugliandolo; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

7.  Human plasma accelerates immortalization of B lymphocytes by Epstein-Barr virus.

Authors:  E Manor
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

Review 8.  Mesenchymal stem cell-based therapy for cartilage repair: a review.

Authors:  Hideyuki Koga; Lars Engebretsen; Jan E Brinchmann; Takeshi Muneta; Ichiro Sekiya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-03-31       Impact factor: 4.342

9.  Mesenchymal stem cell therapy in the sports knee: where are we in 2011?

Authors:  Lee Yee Han Dave; John Nyland; Paul B McKee; David N M Caborn
Journal:  Sports Health       Date:  2012-05       Impact factor: 3.843

10.  Effects of bioactive glass S53P4 or beta-tricalcium phosphate and bone morphogenetic protein-2 and bone morphogenetic protein-7 on osteogenic differentiation of human adipose stem cells.

Authors:  Martin Waselau; Mimmi Patrikoski; Miia Juntunen; Kasperi Kujala; Minna Kääriäinen; Hannu Kuokkanen; George K Sándor; Outi Vapaavuori; Riitta Suuronen; Bettina Mannerström; Brigitte von Rechenberg; Susanna Miettinen
Journal:  J Tissue Eng       Date:  2012-11-23       Impact factor: 7.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.